TNF and rheumatoid arthritis: Clinical studies indicate that antirheumatic treatment, including methotrexate (MTX) and antitumor necrosis factor (anti-TNF) treatment, not only ameliorates disease activity but also reduces CV morbidity and mortality in RA patients [12, 13].